These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31652979)

  • 1.
    Bell CM; Raffeiner P; Hart JR; Vogt PK
    Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31652979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PIK3CA(H1047R) Accelerates and Enhances KRAS(G12D)-Driven Lung Tumorigenesis.
    Green S; Trejo CL; McMahon M
    Cancer Res; 2015 Dec; 75(24):5378-91. PubMed ID: 26567140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ncBAF Complex Regulates Transcription in AML Through H3K27ac Sensing by BRD9.
    Klein DC; Lardo SM; Hainer SJ
    Cancer Res Commun; 2024 Jan; 4(1):237-252. PubMed ID: 38126767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRD9 Inhibition, Alone or in Combination with Cytostatic Compounds as a Therapeutic Approach in Rhabdoid Tumors.
    Krämer KF; Moreno N; Frühwald MC; Kerl K
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28714904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Functional Role and Regulatory Mechanism of Bromodomain-Containing Protein 9 in Human Uterine Leiomyosarcoma.
    Yang Q; Bariani MV; Falahati A; Khosh A; Lastra RR; Siblini H; Boyer TG; Al-Hendy A
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic modulation by targeting bromodomain containing protein 9 (BRD9): Its therapeutic potential and selective inhibition.
    Ali MM; Naz S; Ashraf S; Knapp S; Ul-Haq Z
    Int J Biol Macromol; 2023 Mar; 230():123428. PubMed ID: 36709803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy between BRD9- and IKZF3-Targeting as a Therapeutic Strategy for Multiple Myeloma.
    Chowdhury B; Garg S; Ni W; Sattler M; Sanchez D; Meng C; Akatsu T; Stone R; Forrester W; Harrington E; Buhrlage SJ; Griffin JD; Weisberg E
    Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38610997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research progress of selective small molecule bromodomain-containing protein 9 inhibitors.
    Hui M; Jian Z; Peiyuan Z; Zhenwei W; Huibin Z
    Future Med Chem; 2018 Apr; 10(8):895-906. PubMed ID: 29620420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of imidazo[1,5-a]pyrazin-8(7H)-one derivatives as BRD9 inhibitors.
    Zheng P; Zhang J; Ma H; Yuan X; Chen P; Zhou J; Zhang H
    Bioorg Med Chem; 2019 Apr; 27(7):1391-1404. PubMed ID: 30824168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Degradation of the BAF Complex Factor BRD9 by Heterobifunctional Ligands.
    Remillard D; Buckley DL; Paulk J; Brien GL; Sonnett M; Seo HS; Dastjerdi S; Wühr M; Dhe-Paganon S; Armstrong SA; Bradner JE
    Angew Chem Int Ed Engl; 2017 May; 56(21):5738-5743. PubMed ID: 28418626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition.
    Theodoulou NH; Bamborough P; Bannister AJ; Becher I; Bit RA; Che KH; Chung CW; Dittmann A; Drewes G; Drewry DH; Gordon L; Grandi P; Leveridge M; Lindon M; Michon AM; Molnar J; Robson SC; Tomkinson NC; Kouzarides T; Prinjha RK; Humphreys PG
    J Med Chem; 2016 Feb; 59(4):1425-39. PubMed ID: 25856009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromodomain-Containing Protein 9 Regulates Signaling Pathways and Reprograms the Epigenome in Immortalized Human Uterine Fibroid Cells.
    Yang Q; Vafaei S; Falahati A; Khosh A; Bariani MV; Omran MM; Bai T; Siblini H; Ali M; He C; Boyer TG; Al-Hendy A
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Bromodomain-Containing Protein 9 in Human Uterine Fibroid Cells.
    Yang Q; Falahati A; Khosh A; Vafaei S; Al-Hendy A
    Reprod Sci; 2024 Jun; ():. PubMed ID: 38858328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-140-3p functions as a tumor suppressor in squamous cell lung cancer by regulating BRD9.
    Huang H; Wang Y; Li Q; Fei X; Ma H; Hu R
    Cancer Lett; 2019 Apr; 446():81-89. PubMed ID: 30660651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting BRD9 for Cancer Treatment: A New Strategy.
    Zhu X; Liao Y; Tang L
    Onco Targets Ther; 2020; 13():13191-13200. PubMed ID: 33380808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of bromodomain-containing protein 9 for the prevention of epigenetically-defined drug resistance.
    Crawford TD; Vartanian S; Côté A; Bellon S; Duplessis M; Flynn EM; Hewitt M; Huang HR; Kiefer JR; Murray J; Nasveschuk CG; Pardo E; Romero FA; Sandy P; Tang Y; Taylor AM; Tsui V; Wang J; Wang S; Zawadzke L; Albrecht BK; Magnuson SR; Cochran AG; Stokoe D
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3534-3541. PubMed ID: 28606761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas.
    Bouillez A; Rajabi H; Pitroda S; Jin C; Alam M; Kharbanda A; Tagde A; Wong KK; Kufe D
    Cancer Res; 2016 Mar; 76(6):1538-48. PubMed ID: 26833129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BRD9 degraders as chemosensitizers in acute leukemia and multiple myeloma.
    Weisberg E; Chowdhury B; Meng C; Case AE; Ni W; Garg S; Sattler M; Azab AK; Sun J; Muz B; Sanchez D; Toure A; Stone RM; Galinsky I; Winer E; Gleim S; Gkountela S; Kedves A; Harrington E; Abrams T; Zoller T; Vaupel A; Manley P; Faller M; Chung B; Chen X; Busenhart P; Stephan C; Calkins K; Bonenfant D; Thoma CR; Forrester W; Griffin JD
    Blood Cancer J; 2022 Jul; 12(7):110. PubMed ID: 35853853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma.
    Kurata K; Samur MK; Liow P; Wen K; Yamamoto L; Liu J; Morelli E; Gulla A; Tai YT; Qi J; Hideshima T; Anderson KC
    Clin Cancer Res; 2023 May; 29(9):1807-1821. PubMed ID: 36780189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of oncogenic KRAS signaling via a novel KRAS-integrin-linked kinase-hnRNPA1 regulatory loop in human pancreatic cancer cells.
    Chu PC; Yang MC; Kulp SK; Salunke SB; Himmel LE; Fang CS; Jadhav AM; Shan YS; Lee CT; Lai MD; Shirley LA; Bekaii-Saab T; Chen CS
    Oncogene; 2016 Jul; 35(30):3897-908. PubMed ID: 26616862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.